References
- Graybill J.R., Taylor R.L. Host defense in cryptococcosis. I. An in vivo model for evaluating immune response. International Archives of Allergy and Applied Immunology 1978; 57: 101–113
- Graybill J.R., Mitchell L., Levine H.B. Treatment of experimental murine cryptococcosis: a comparison of miconazole and amphotericin B. Antimicrobial Agents and Chemotherapy 1978; 13: 277–283
- Graybill J.R., Craven P.C., Mitchell L., Drutz D.J. Interaction of chemotherapy and immune defenses in experimental murine cryptococcosis. Antimicrobial Agents and Chemotherapy 1978; 14: 659–667
- Huppert M., Sun S.H., Vukovich K.R. Combined amphotericin B-tetracycline therapy for experimental coccidioidomycosis. Antimicrobial Agents and Chemotherapy 1974; 5: 473–478
- Kitahara M., Kobayashi G.S., Medoff G. Enhanced efficacy of amphotericin B and rifampicin combined in treatment of murine histoplasmosis and blastomycosis. Journal of Infectious Diseases 1976; 133: 663–668
- Kobayashi G.S., Medoff G., Schlessinger D., Kawn C.N., Musser W.E. Amphotericin B potentiation of rifampicin as an antifungal agent against the yeast phase of Histoplasma capsulatum. Science 1972; 177: 709–810
- Lew M.A., Beckett K.M., Levin M.J. Combined activity of minocycline and amphotericin B in vitro against medically important yeasts. Antimicrobial Agents and Chemotherapy 1978; 14: 465–469
- O'Connell C.J., Gehl J., Klyde B. Practical notes on antibiotic bioassay by the disk method. American Journal of Clinical Pathology 1973; 59: 384–387